Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 4 Date: 02 Sep 2024
Reviewer:  Mukesh Ranjan
Reviewer's report:
I want to congratulate authors for a good work.
Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 4 Date: 02 Sep 2024
Reviewer:  Mukesh Ranjan
Reviewer's report:
I want to congratulate authors for a good work.
Please review this paper.
user
Title: The efficacy of CT-P13, a biosimilar of infliximab, in inflammatory bowel diseases: A
systematic review and meta-analysis
Version: 4 Date: 02 Sep 2024
Reviewer:  Mukesh Ranjan
Reviewer's report:
I want to congratulate authors for a good work.
assistant